Indian Pharma Manufacturers: What's the Biggest Hurdle?

Indian pharma manufacturers face a mix of big challenges today. The main one? Struggling to keep up with changing global quality rules while staying affordable. Many companies feel squeezed between rising compliance costs and price-sensitive markets. Tougher inspections from the US and Europe, plus pressure at home around drug quality, make things even trickier. This article unpacks what's at stake and what players can do right now.